PITFALLS IN THE MANAGEMENT OF THE POISONED PATIENT

1 Greaves I S Goodacre Grout P. Management of drug overdose in accident and emergency departments in the United Kingdom. J Accident Emerg Med 1996; 13:46–8.

2 Flanagan RJ Rooney C. Recording acute poisoning deaths. Forensic Sci Int 2002; 128(1–2):3–19.

3 Ramsay LE S Freestone Silas JH. Drug-related acute medical admissions. Hum Toxicol 1982; 1(4):379–86.

4 Townsend E K Hawton Harriss L Substances used in deliberate self-poisoning 1985–1997: trends and associations with age, gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol 2001; 36:228–34.

5 Hawton K Fagg J. Deliberate self-poisoning and selfinjury in adolescents: a study of characteristics and trends in Oxford, 1976–89. Br J Psychiatry 1997; 171(12):556–60.

6 Schmidtke A U Bille-Brahe Deleo D Attempted suicide in Europe: rates, trends, and sociodemographic characteristics of suicide attempters during the period 1989–1992. Results of the WHO/EURO multicentre study on parasuicide. Acta Psychiatrica Scandinavica1996; 93:327–38.

7 Michel K P Ballinari Bille-Brahe U Methods used for parasuicide: results of the WHO/EURO Multicentre Study on Parasuicide. Soc Psychiatry Psychiatr Epidemiol 2000; 35(4):156–63.

8 Jones AL Dargan PI. Churchill’s Pocketbook of Toxicology. Edinburgh: Churchill Livingston, Harcourt; 2001.

9 Litovitz TL W Klein-Schwartz Rogers CJ Jr 2001 Annual Report of the American Association of Poison Control Centres Toxic Exposure Surveillance System. Am J Emerg Med 2002; 20:391–452.

10American Academy of Clinical Toxicology; European Association of Poison Control Centres and Clinical Toxicologists. Position statement: Single-dose activated charcoal. Clin Tox 1997; 35(7):721–41.

11 Thakore S Murphy N. The potential role of prehospital administration of activated charcoal. Emerg Med J 2002; 19:63–5.

12 Karim A S Ivatts Dargan PI How feasible is it to conform to the European guidelines on the administration of activated charcoal within one hour of overdose? Emerg Med J 2001; 18:390–2.

13American Academy of Clinical Toxicology; European Association of Poison Control Centres and Clinical Toxicologists. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. Clin Tox 1999; 37(6):731–51.

14 Saetta JP S March Gaunt ME Gastric emptying procedures in the self poisoned patient: are we forcing gastric content beyond the pylorus? J R Soc Med 1991; 84:274–6.

15American Academy of Clinical Toxicology and European Association of Poisons Centres. Position statement: Gastric lavage. Clin Tox1997; 35(7):711–19.

16American Academy of Clinical Toxicology and European Association of Poisons Centres. Position statement: Whole bowel irrigation. Clin Tox 1997; 35:735–62.

17 Dargan PI GY Shin Jones AL. How well do doctors and nurses estimate the weight of patients? J Toxicol Clin Toxicol 2001; 39:567–8.

18 Hawton K E Townsend Deeks J Effects of legislation restricting pack sizes of paracetamol and salicylate on self-poisoning in the UK: before and after study. BMJ 2001; 322:1203–7.

19 Parfitt A Henry JA. Troublesome toxins. Emerg Med J 2002; 19:192–3.

20NPIS. Management of acute paracetamol poisoning. Guidelines agreed by the UK National Poisons Information Service 1998. Supplied to the Accident and Emergency Centres in the UK by the Paracetamol Information Centre in collaboration with the British Association for Accident and Emergency Medicine.

21 Wallace CI PI Dargan Jones AL. Paracetamol overdose: an evidence-based flowchart to guide management. Emerg Med J 2002; 19:202–5.

22 Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol 2000; 49:291–301.

23 Bray GP C Mowat Muir DF The effect of chronic alcohol intake on prognosis and outcome in paracetamol overdose. Hum Exp Toxicol 1991; 10:435–8.

24 Wright N Prescott LF. Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdose. Scott Med J 1973; 18:56–8.

25 Smith JA ID Hine Beck P Paracetamol toxicity: is enzyme induction important? Hum Exp Toxicol 1986; 5:383–5.

26 Minton N JA Henry Frankel RJ. Fatal paracetamol poisoning in an epileptic. Hum Exp Toxicol 1988; 7:33–4.

27 Whitcomb DC Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272:1845–50.

28 Buhl R HA Jaffe Holroyd KA Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989; ii:1294–8.

29 Routledge PA JA Vale Bateman DN Paracetamol (acetaminophen) poisoning. BMJ 1998; 317:1609–10.

30 Prescott LF RN Illingworth Critchley JA Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ 1979; 2:1098–100.

31 Jones AL. Mechanism of action of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J Toxicol Clin Tox 1998; 36:277–85.

32 Singer AJ TR Carracio Mofenson HC. The temporal profile of increased transaminase levels in patients with acetaminophen induced liver dysfunction. Ann Emerg Med 1995; 26:49–53.

33 Harrison PM JG O’Grady Keays RT Serial prothrombin time as a prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ; 301:964–6.

34 Record CO RA Iles Cohen RD Acid-base and metabolic disturbances in fulminant hepatic failure. Gut 1975; 16:144–9.

35 Blantz RC. Acetaminophen, acute and chronic effects on renal function. Am J Kidney Dis 1996; 28(1 Suppl 1):S3–6.

36 Eguia L Materson BJ. Acetaminophen-related acute renal failure without fulminant liver failure. Pharmacotherapy 1997; 17:363–70.

37 Prescott LF AT Proudfoot Creegan RJ. Paracetamol induced renal failure in the absence of fulminant liver damage. BMJ 1992; 284:421–2.

38 Vale JA Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995; 346:547–52.

39 Prescott LF Critchley JA. The treatment of acetaminophen poisoning. Ann Rev Pharmacol Toxicol 1983; 23:87–101.

40 Fellay M Kehtari R. Insuffisance hepatique fulminante et subfulminante. Rev Med Suisse Romande 1996; 116:483–91.

41 Makin AJ J Wendon Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987–93). Gastroenterology 1995; 109:1907–16.

42 Makin A Williams R. The current management of paracetamol overdosage. Br J Clin Pharmacol 1994; 48:144–8.

43 O’Grady JG J Wendon Tan KC Liver transplantation after paracetamol overdose. BMJ 1991; 303:221–3.

44 Wendel A H Jaeschke Gloger M. Drug induced lipid peroxidation in mice – protection against paracetamol induced liver necrosis by intravenous liposomally entrapped glutathione. Biochem Pharmacol 1982; 31:3601–5.

45 Prescott LF. Paracetamol (acetaminophen). A critical bibliographic review. London: Taylor and Francis; 1996.

46 Linden CH Rumack BH. Acetaminophen overdose. Emerg Clin North Am 1984; 2:103.

47 Henretig FM SM Selbst Forrest C Repeated acetaminophen overdosing causing hepatotoxicity in children: clinical reports and literature review. Clin Pediatr 1989; 28:525–8.

48 Sadove MS RC Balagot Hatano S Study of a narcotic antagonist – n-allyl-noroxymorphone. JAMA 1963; 183:666–8.

49 Allen SC. Problems with naloxone (letter). BMJ 1975; 3:434.

50 Wikler A HF Fraser Isbell H. N-allylnormorphone: effects of single doses and precipitation of acute ‘abstinence syndromes’ during addiction to morphine, methadone or heroin in man (post-addicts). J Pharmacol Exp Ther 1953; 109:8–20.

51 Evans LEJ P Roscoe Swainson CP Treatment of drug overdosage with naloxone, a specific narcotic antagonist. Lancet 1973; i:452–5.

52 Buchwald A. Naloxone use: side effects may occur (letter). Ann Emerg Med 1988; 17:765.

53 Popper C GD Kelen Cunningham G. Naloxone hazard in a drug abuser. Lancet 1989; 2(8666):446.

54 Gibbs J T Newson Williams J Naloxone hazard in infant of opioid abuser (letter). Lancet 1989; 2(8655):159.

55 Gaddis G Watson WA. Naloxone–associated patient violence: an overlooked toxicity? Ann Pharmacotherapy 1992; 26:196–7.

56 Martin WR. Naloxone: diagnosis and treatment. Ann Intern Med 1976; 85:765–8.

57 Fishman J H Roffwarg Hellman L. Disposition of naloxone in normal and narcotic dependent men. J Pharmacol Exp Ther 1973; 187:575–80.

58 Lasagna L. The clinical evaluation of morphine and its substitutes as analgesics. Pharmacol Rev 1964; 16:47–83.

59 Murphree HB. Clinical pharmacology of potent analgesics. Clin Pharmacol Ther 1962; 3:473–504.

60 Goldfrank L RS Weisman Errick JK A dosing nomogram for continuous infusion intravenous naloxone. Ann Emerg Med 1986; 566:91–5.

61 Wilson RC PJ Saunders Smith G. An epidemiological study of acute carbon monoxide poisoning in the West Midlands. Occup Env Med 1998; 55:723–8.

62 Gorman DF D Clayton Gilligan JE A longitudinal study of 100 consecutive admissions for carbon monoxide poisoning to the Royal Adelaide Hospital. Anaesth Intensive Care 1992; 20:311–16.

63 Thom SR Keim LW. Carbon monoxide poisoning: a review of epidemiology, pathophysiology, clinical findings, and treatment options including hyperbaric oxygen therapy. Clin Toxicol 1989; 27:141–56

64 Yanir Y A Shupak Abramovich A Cardiogenic shock complicating acute carbon monoxide poisoning despite neurological and metabolic recovery. Ann Emerg Med 2002; 40:420–4.

65 Ernst A Zibrak JD. Carbon monoxide poisoning. N Engl J Med 1998; 339:1603–8.

66 Miro O J Casademont Barrientos A Mitochondrial cytochrome oxidase inhibition during acute carbon monoxide poisoning. Pharmacol Toxicol 1998; 82:199–202.

67 Diltoer MW IO Colle Hubloue I Reversible cardiac failure in an adolescent after prolonged exposure to carbon monoxide. Eur J Emerg Med 1995; 2:231–5.

68 Tritapepe L G Macchiarelli Rocco M Functional and ultrastructural evidence of myocardial stunning after acute carbon monoxide poisoning. Crit Care Med 1998; 26:797–801.

69 McMeekin JD Finegan BA. Reversible myocardial dysfunction following carbon monoxide poisoning. Can J Cardiol 1987; 3:118–21.

70 Kubat K Zboril M. Determination of serum lactic acid and the acid-base equilibrium in carbon monoxide poisoning. Vnitr Lek 1995; 45:545–8.

71 Buckley RG SE Aks Ashom JL The pulse oximetry gap in carbon monoxide intoxication. Ann Emerg Med 1994; 24:252–5.

72 Ducasse JL P Celsius Marc-Vergnes JP. Non-comatose patients with acute carbon monoxide poisoning: hyperbaric or normobaric oxygenation? Undersea Hyperb Med 1995; 22:1–9.

73 Mathieu D F Wattel Mathieu-Nolf M. Randomised prospective study comparing the effect of hyperbaric oxygen versus 12 hours non-hyperbaric oxygen in noncomatose CO poisoned patients: results of the interim analysis. Undersea Hyperb Med 1996; 23:7–8.

74Raphael J-C, Elkarrat D, Jars-Guincestre MC Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989; ii:414–19.

75 Scheinkestel CD M Biley Myles PS Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled trial. Med J Aust 1999; 170:203–10.

76 Thom SR RL Tber I Mendiguren Clark JM Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med 1995; 25:474–80.

77 Weaver LK RO Hopkins Chan KJ Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med 2002; 347(14):1057–67.

78 Jones AL. Recent advances in the management of poisoning. Ther Drug Monit 2002; 24:150–5.

79 Taboulet P FJ Baud Bismuth C. Clinical features and management of digitalis poisoning rationale for immunotherapy. J Toxicol Clin Toxicol 1993; 31:247–60.

80 Smolarz A E Roesch Lenz E Digoxin specific antibody (Fab) fragments in 34 cases ofsevere digitalis intoxication. J Toxicol Clin Toxicol 1985; 23:327–40.

81 Taboulet P FJ Baud Bismuth C Acute digitalis intoxication – is pacing still appropriate? J Toxicol Clin Toxicol 1993; 31:261–73.

82 Lange RA Hillis LD. Medical progress: cardiovascular complications of cocaine use. N Engl J Med 2001; 345(5):351–8.

83 Stouffer GA RG Sheahan Lenihan DJ Cocaineassociated chest pain. Amer J Med Sci 2002; 324(1):37–44.

84 Beckman KJ RB Parker Hariman RJ Hemodynamic and electrophysiological actions of cocaine. Circulation 1991; 83:1799–807.

85 Flores ED RA Lange Cigarroa RG Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. J Am Coll Cardiol 1990; 16:74–9.

86 Brogan WC RA Lange Kim AS Alleviation of cocaineinduced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 1991; 18:581–6.

87 Hollander JE RS Hoffman Gennis P Nitroglycerin in the treatment of cocaine associated chest pain – clinical safety and efficacy. Clin Toxicol 1994; 32:243–56.

88 Negus BH JE Willard Hillis LD Alleviation of cocaineinduced coronary vasoconstriction with intravenous verapamil. Am J Cardiol 1994; 73:510–13.

89. Sandeman DJ TI Alahakoon Bentley SC. Tricyclic poisoning – successful management of ventricular fibrillation following massive overdose of imipramine. Anaesth Intensive Care 1997; 25(5):542–5.

90 Evans JS Oram MP. Neurological recovery after prolonged verapamil-induced cardiac arrest. Anaesth Intensive Care 1999; 27(6): 653–5.

91 Cordova S Lee R. Fixed dilated pupils in the ICU: another recoverable cause. Anaesth Intensive Care 2000; 28(1):91–3.

92 Christiaens F H Lessire Dellers I Successful prolonged cardiopulmonary resuscitation after a combined intoxication with a tricyclic antidepressant, a benzodiazepine and a neuroleptic. Eur J Emerg Med 2000; 7(3):229–36.

93European Resuscitation Council. Part 8: advanced challenges in resuscitation. Section 2: toxicology in ECC. Resuscitation 2000; 46(1–3):261–6.

94American Academy of Clinical Toxicology. Practice guidelines on the treatment of methanol poisoning. Clin Toxicol 2002; 40(4):415–46.

95 Brent J. Current management of ethylene glycol poisoning. Drugs 2001; 61(7):979–88.

96 McMartin KE JJ Ambre Tephly TR Methanol poisoning in human subjects. Role for formic acid accumulation in the metabolic acidosis. Am J Med 1980; 68:414–18.

97 Shanangian S Formic Ash KO. acidosis lactic in a fatal case of methanol intoxication. Clin Chem 1986; 32:395–7.

98 Purssell RA M Pudek J Brubacher Derivation Abu-Laban RB. of validation a formula to calculate the contribution of ethanol to the osmolal gap. Ann Emerg Med 2001; 38:653–9.

99 Jacobsen D Methanol McMartin KE. glycol ethylene poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol 1986; 1:309–34.

100 Kowalczuk M S Halvosen Ovrebo S Ethanol treatment in ethylene glycol poisoned patients. Vet Hum Toxicol 1998; 4:225–8.

101 Olsen KR , editor. Poisoning and drug overdose. Stamford, CN: Appleton and Lange; 1999.

102 McCabe JL DJ Cobaugh Menegazzi JJ Experimental tricyclic antidepressant toxicity: a randomized, controlled comparison of hypertonic saline solution, sodium bicarbonate, and hyperventilation. Ann Emerg Med 1998; 32:329–33.

103 Blackman K SG Brown Wilkes GJ. Plasma alkalinisation for tricyclic antidepressant toxicity: a systemic review. Emerg Med (Fremantle) 2001; 13:204–10.

104 Hoffman JR SR Votey Bayer M Effect of hypertonic sodium bicarbonate in the treatment of moderate-tosevere tricyclic antidepressant overdose. Am J Emerg Med 1993; 11:336–41.

105 Burg F. Intoxications volontaires par la chloroquine. These Medecine. Strasbourg: Universite Louis Pasteur; 1976.

106 Conso F. Death from acute poisoning in man. Vet and Hum Toxicol 1979; 21:68–9.

107 Goldfrank LR , editor. Goldfrank’s Toxicologic Emergencies. 6th ed. Stamford, CN: Appleton and Lange; 1998; 745.

108 Vitris M Aubert M. Intoxications a la chloroquine: notre experience a propos de 80 cas. Dakar Medical 1983; 28:593–602.

109 Clemessy JL P Taboulet Hoffman JR Treatment of acute chloroquine poisoning: a 5-year experience. Crit Care Med 1996; 24:1189–95.

110 Riou B A Rimailho Galliot M Protective cardiovascular effects of diazepam in experimental acute chloroquine poisoning. Intensive Care Med 1998; 14:610–16.

111 Neuvonen PJ KT Kivisto Laine K Prevention of chloroquine absorption by activated charcoal. Hum Exp Toxicol 1992; 11:117–20.

112 Jaeger A O Raguin Liegeon MN. Acute poisoning by Class 1 antiarrhythmic agents and by chloroquine. Rev Prat 1997; 47:748–53.

113 Jaeger A P Sauder Kopferschmitt J Clinical features and management of poisoning due to antimalarialdrugs. Med Tox 1987; 2:242–73.

114 Clemessy JL C Favier Borron SW Hypokalaemia related to acute chloroquine ingestion. Lancet 1995; 346:877–80.

115 Bouvier AM D Bertrand Timsit JF Intoxications massives et prolongees par la nivaquine: effets du diazepam. Reanimation Soins Intensifs, Medicine d’Urgence 1986; 2:265.

116 Riou B P Barriot Rimailho A Treatment of severe chloroquine poisoning. New Engl J Med 1988; 318:1–6.

117 Bateman DN Dyson EH. Quinine toxicity. Adv Drug React Ac Pois Rev 1986; 5(4):215–33.

118 Dargan PI CI Wallace Jones AL. An evidence-based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J 2002; 19:206–9.

119 Brenner BE Simon RR. Management of salicylate intoxication. Drugs 1982; 24:335–40.

120 Temple AR. Acute and chronic effects of aspirin toxicity and their treatment. Arch Intern Med 1981; 141:364–9.

121 Chapman BJ Proudfoot AT. Adult salicylate poisoning: deaths and outcome in patients with high salicylate concentrations. Q J Med 1989; 72:699–707.

122 Higgins RM JO Connolly Alkalinisation Hendry BM. in hemodialysis severe salicylate poisoning: comparison of elimination techniques in the same patient. Clin Nephrol 1998; 50:178–83.

123 Proudfoot AT. Toxicity of salicylates. Am J Med 1983; 75:99–103.

124 Prescott LF M Balali-Mood Critchley JA Diuresis or urinary alkalinisation for salicylate poisoning? BMJ (Clin Res Ed) 1982; 285:1383–6.

125 Hillman RJ Prescott LF. Treatment of salicylate poisoning with repeated oral charcoal. BMJ (Clin Res Ed) 1985; 291:1472.

126 Kirshenbaum LA SC Mathews Sitar DS Does multiple-dose activated charcoal therapy enhance salicylate excretion? Arch Intern Med 1990; 150:1281–3.

127 Barone JA JJ Raia Chain Y. Evaluation of the effects of multiple-dose activated charcoal on the absorption of orally administered salicylates in a simulated toxic ingestion model. Ann Emerg Med 1988; 17:34–7.

128 Done AK. Salicylate intoxication: significance of measurements of salicylate in blood in cases of acute intoxication. Pediatrics 1960; 26:800–7.

129 Thisted B T Krantz Stroom J Acute salicylate selfpoisoning in 177 consecutive patients treated in the ICU. Acta Anaesthesiol Scand 1987; 31:312–16.

130 Todd PJ JA Sills Harris F Problems with overdoses of sustained-release aspirin. Lancet 1981; 1(8232):777.

131 Kwong TC J Laczin Baum J. Self-poisoning with entericcoated aspirin. Am J Clin Pathol 1983; 80:888–90.

132 Wortzman DJ Grunfeld A. Delayed absorption following enteric-coated aspirin overdose. Ann Emerg Med 1987; 16:434–6.

133 Henderson A DM Wright Pond SM. Management of theophylline overdose patients in the intensive care unit. Anaesth Intensive Care 1992; 20(1):56–62.

134 Sessler CN. Theophylline toxicity: clinical features of 116 cases. Am J Med 1990; 88:567–76.

135 Gaudreault P S Wason Lovejoy Jr FH. Acute pediatric theophylline overdose: a summary of 28 cases. Journal of Pediatrics 1983; 102:474–6.

136 Sessler CN FL Glauser Cooper KR. Treatment of theophylline toxicity with oral activated charcoal. Chest 1985; 87:325–9.

137 Sessler CN FL Glauser Cooper KR. Treatment of theophylline toxicity with oral activated charcoal. Chest 1985; 87:325–9.

138 Minton NA Henry JA. Treatment of theophylline overdose. Am J Emerg Med 1996; 14:606–12.

139 Brown SGA Prentice DA. Ondansetron in the treatment of theophylline overdose. Med J Austr 1992; 156:512.

140 Sage TA WN Jones Clark RF. Ondansetron in the treatment of intractable nausea associated with theophylline toxicity. Ann Pharmacother 1993; 27:584–5.

141 Vestal RE CE Eiriksson Jr Musser B Effect of intravenous aminophylline onplasma levels of catecholamines and related cardiovascular and metabolic responses in man. Circulation 1983; 67:162–71.

142 Kearney TE AS Manoguerra Curtis GP Theophylline toxicity and the beta-adrenergic system. Ann Intern Med 1985; 102:766–9.

143 Biberstein MP MG Fiegler Ward DM. Use of betablockade and hemoperfusion for acute theophylline poisoning. West J Med 1984; 141:485–90.

144 Amin DA Henry JA. Propranolol administration in theophylline intoxication. Lancet 1985; 1:520–1.

145 Seneff M J Scott Friedman B Acute theophylline toxicity and the use of esmolol to reverse cardiovascular instability. Ann Emerg Med 1990; 19:671–3.

146Vanden Hoek T, Murphy C, Aks S The use of esmolol to reverse unstable supraventricular tachycardia in a theophylline toxic patient. Vet Hum Toxicol 1991; 33:390.

147 Levine JH JR Michael Guarnieri T. Treatment of multifocal atrial tachycardia with verapamil. N Engl J Med 1985; 312:21–5.

148 Heath A Knudsen K. Role of extracorporeal drug removal in acute theophylline poisoning. Med Toxicol 1987; 2:294–308.

149 Park GD R Spector Roberts RJ Use of hemoperfusion for the treatment of theophylline intoxication. Am J Med 1983; 74:961–6.

150 Covey TJ. Ferrous sulphate poisoning: a review, case summaries, and therapeutic regimen. J Pediatr 1964; 64:218–26.

151 Mehta M. Acute iron poisoning. Indian J Pediatr 1997; 64:485–93.

152British National Formulary. Great Britain: Scottish Executive Health Department; 2001; 44, 444.

153 Tenenbein M. Whole bowel irrigation in iron poisoning. J Pediatr 1987; 111:142–5.

154 Fine JS. Iron poisoning. Curr Probl Pediatr 2000; 30(3):70–90

155 Helfer RE Rodgerson DO. The effect of deferoxamine on the determination of serum iron and iron-binding capacity. J Pediatr 1996; 68:804–6.

156 Gervitz NR Wasserman LR. The measurement of iron and iron-binding capacity in plasma containing deferioxamine. J Pediatr 1966; 68:802.

157 Siff JE SW Meldon Tomassoni AJ. Usefulness of the total iron binding capacity in the evaluation and treatment of acute iron overdose. Ann Emerg Med 1999; 33:73–6.

158 Tenenbein M. Benefits of parenteral deferoxamine for acute iron poisoning. Clin Tox 1996; 34(5):485–9

159 Westluin WF. Deferoxamine as a chelating agent. J Toxicol Clin Toxicol 1971; 4:597–602.

160 Howland MA. Risks of parenteral deferoxamine for acute iron poisoning. J Toxicol Clin Toxicol 1996; 339:699–701.

161 Banner W DD Vernon Ward RM Continuous haemofiltration in experimental iron intoxication. Crit Care Med 1989; 17:1187–90.

162 Lundquist P Sorbo B. Rapid determination of toxic cyanide concentrations in blood. Clin Chem 1989; 35:617–19.

163 Laforge M F Buneaux Houeto P A rapid spectrophotometric blood cyanide determination applicable to emergency toxicology. J Anal Toxicol 1994; 8:173–5.

164 Vesey CJ H McAllister Langford RM. A simple rapid and sensitive semimicro method for the measurement of cyanide in blood. Ann Clin Biochem 1999; 26:755–8.

165Berlin Jr CM. The treatment of cyanide poisoning in children. Pediatrics 1970; 46:793–6.

166 Dodds C McKnight C. Cyanide toxicity after immersion and hazards of dicobalt edetate. BMJ 1985; 291:785–6.

167 Baud FJ SW Boron Megarbane B Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med 2002; 30(9):2044–50.

168 Baud FJ P Barriot Toffis V Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med 1991; 325:1761–6.

169 George C K Ramsay Rochester M Facilities for chemical decontamination in accident and emergency departments in the United Kingdom. Emerg Med J 2002; 19:453–7.

170 Graham DL D Laman Theodore J Acute cyanide poisoning complicated by lactic acidosis and pulmonary oedema. Arch Intern Med 1977; 137:1051–5.

171 Prien T. Toxic smoke compounds and inhalation injury – a review. Burns 1988; 14:451–60.

172 Hall AH Rumack BH. Clinical toxicology of cyanide. Ann Emerg Med 1986; 15:1067–74.

173 Dodds C McKnight C. Cyanide toxicity after immersion and the hazards of dicobalt edetate. BMJ 1985; 291:785–6.

174Pronczuk de Garbino JP, Bismuth C. Propositions therapeutiques actuelles en cas d’intoxication par les cyanures. Toxicol Eur Res 1981; 3:69–76.

175 Davison V. Cyanide poisoning: kelocyanor – a new treatment. Occup Health 1969; 21:306–8.

176 Hall AH Hydroxocobalamin Rumack BH. , sodium thiosulphate as a cyanide antidote. J Emerg Med 1987; 5:115–21.

177 Johnson WS AH Hall Rumack BH. Cyanide poisoning successfully treated without ‘therapeutic methaemoglobin levels’. Am J Emerg Med 1989; 7:437–40.

178 Kirk MA R Gerace Cyanide Kulig KW. kinetics methaemoglobin in smoke inhalation victims treated with the cyanide antidote kit. Ann Emerg Med 1993; 22:1413–18.

179 Houeto P SW Borron Sandouk P Pharmacokinetics of hydroxocobalamin in smoke inhalation victims. J Toxicol Clin Toxicol 1996; 34:397–404.

180 Houeto P JR Hoffman Imbert M Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning. Lancet 1995; 346:605–8.

181 Beasley DM Glass WI. Cyanide poisoning: pathophysiology and treatment recommendations. Occup Med 1998; 48:427–31.